Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity is a research paper published in RSC Chemical Biology (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: GM135218
National Institute of General Medical Sciences
Grant: GM137286
National Institute of General Medical Sciences
Grant: GM152079
Division of Graduate Education
Grant: 1650116
NIGMS NIH HHS
Grant: R01 GM137286
NIGMS NIH HHS
Grant: R35 GM152079
NIDDK NIH HHS
Grant: P30 DK056350
NIGMS NIH HHS
Grant: R01 GM135218
Crohn's & Colitis Foundation
Grant: 708151
National Institutes of Health
Grant: 5R01GM135218-03
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes
National Institutes of Health
Grant: 5R01GM137286-04
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health
National Institutes of Health
Grant: 5R35GM152079-02
Gut Microbial Enzymes and Human Disease
FWCI
1.00
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals